Prophylaxis and Treatment of Pneumocystis jiroveci Pneumonia in Lymphoma Patients Subjected to Rituximab-Contained Therapy: A Systemic Review and Meta-Analysis

por Jiang, Xuqin, Mei, Xiaodong, Feng, Di, Wang, Xiaojing
Publicado 2015

Coagulation dysfunction in patients with AECOPD and its relation to infection and hypercapnia

por Liu, Mei, Hu, Ruixue, Jiang, Xuqin, Mei, Xiaodong
Publicado 2021

Competing PM(2.5) and NO(2) holiday effects in the Beijing area vary locally due to differences in residential coal burning and traffic patterns

por Hua, Jinxi, Zhang, Yuanxun, de Foy, Benjamin, Mei, Xiaodong, Shang, Jing, Feng, Chuan
Publicado 2021

COVID-19 pandemic in Wuhan: Ambient air quality and the relationships between criteria air pollutants and meteorological variables before, during, and after lockdown

por Sulaymon, Ishaq Dimeji, Zhang, Yuanxun, Hopke, Philip K., Zhang, Yang, Hua, Jinxi, Mei, Xiaodong
Publicado 2021

Metagenomic Next-Generation Sequencing Is Highly Efficient in Diagnosing Pneumocystis Jirovecii Pneumonia in the Immunocompromised Patients

por Wang, Dongsheng, Fang, Shihua, Hu, Xiaowen, Xu, Qixia, Chu, Xinmin, Mei, Xiaodong, Xie, Wang
Publicado 2022

Quantitative estimation of meteorological impacts and the COVID-19 lockdown reductions on NO(2) and PM(2.5) over the Beijing area using Generalized Additive Models (GAM)

por Hua, Jinxi, Zhang, Yuanxun, de Foy, Benjamin, Shang, Jing, Schauer, James J., Mei, Xiaodong, Sulaymon, Ishaq Dimeji, Han, Tingting
Publicado 2021

Persistent high PM(2.5) pollution driven by unfavorable meteorological conditions during the COVID-19 lockdown period in the Beijing-Tianjin-Hebei region, China

por Sulaymon, Ishaq Dimeji, Zhang, Yuanxun, Hopke, Philip K., Hu, Jianlin, Zhang, Yang, Li, Lin, Mei, Xiaodong, Gong, Kangjia, Shi, Zhihao, Zhao, Bin, Zhao, Fangxin
Publicado 2021

Efficacy And Safety Of Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler (GFF MDI) Formulated Using Co-Suspension Delivery Technology In Chinese Patients With COPD

por Chen, Rongchang, Zhong, Nanshan, Wang, Hao-Yan, Zhao, Li, Mei, Xiaodong, Qin, Zhiqiang, Huang, Juan, Assam, Pryseley N, Maes, Andrea, Siddiqui, Shahid, Martin, Ubaldo J, Reisner, Colin
Publicado 2020

Tocilizumab in patients with moderate or severe COVID-19: a randomized, controlled, open-label, multicenter trial

por Wang, Dongsheng, Fu, Binqing, Peng, Zhen, Yang, Dongliang, Han, Mingfeng, Li, Min, Yang, Yun, Yang, Tianjun, Sun, Liangye, Li, Wei, Shi, Wei, Yao, Xin, Ma, Yan, Xu, Fei, Wang, Xiaojing, Chen, Jun, Xia, Daqing, Sun, Yubei, Dong, Lin, Wang, Jumei, Zhu, Xiaoyu, Zhang, Min, Zhou, Yonggang, Pan, Aijun, Hu, Xiaowen, Mei, Xiaodong, Wei, Haiming, Xu, Xiaoling
Publicado 2021